BRCA1 and breast carcinoma: However, in France, women presenting with these mutations are not included in the organized nationwide screening and, as explained in PROCAS12, mutations in breast cancer genes such as BRCA1 and BRCA2 are too infrequent to affect risk prediction appreciably in the models for the general population.